| Factor Information | |
|---|---|
| Data ID | 663 |
| Factor | small for gestational age infant(SGA) |
| Description | N/A |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | To compare the differences in adverse outcome of neonates with PAH-CHD |
| p Value | 0.023 |
| Conclusion | The proportion of SGA was higher in severe PAH group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 474 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/PDA/ECD/TOF/EA/DORV/VSD, ES/PDA, ES/ASD, VSD, PDA, ES/ASD, ES |
| Reference | |
|---|---|
| PMID | 29136712 |
| Year | 2017 |
| Title | Long-term outcome and prognostic factors in pregnant women with pulmonary arterial hypertension associated with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | pregnant women | |
| Source | data | |
| Region | China, Beijing | |
| Method | univariate analysis | |
| Race | Asian | |
| Disease History | mother with PAH | |
| Treatment History | N/A | |
| Group | severe PAH(Treatment) | moderate PAH / mild PAH(Control) |
| Number | 66 | 33(moderate PAH), 11(mild PAH) |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.197 | 3.0%(moderate PAH), 9.1%( mild PAH) |
